Suki announced on Oct. 13, 2026, that it raised $90 million in a Series E funding round aimed at accelerating growth and expanding the company’s artificial intelligence capabilities. New investors in the round included Healthier Capital, Crosslink Capital and Hercules Capital, and all of Suki’s existing institutional backers — including Venrock, Flare Capital Partners, Hedosophia, Philips Ventures and Zoom Ventures — also participated.
The company said the fresh capital will be directed at three priorities: advancing its AI, expanding the commercial organization and scaling its partner ecosystem. Suki’s CEO and founder, Punit Soni, described the move as part of a broader effort to move healthcare AI beyond narrow documentation use cases toward intelligence that supports clinical decisions, improves financial performance and streamlines operations.
Suki reported substantial usage and revenue momentum. Patient encounters supported by its tools grew more than 190% year over year in 2026, the company said. Revenue doubled in 2025, and Suki said it was on track for similar revenue growth in 2026. The company now works with more than 250 healthcare organizations and counts over 30 technology partners that embed its AI into their platforms.
Executives framed these metrics as evidence of demand for AI that is embedded into clinician workflows and broader health system operations rather than isolated point solutions.
With this Series E round, Suki said it has raised more than $250 million in total funding. The financing brings new investor representation to the company’s board: Healthier Capital Partner Aman Mahajan, M.D., Ph.D., will join Suki’s board as part of the transaction.
Mahajan commented that the opportunity for AI in healthcare goes beyond automating individual tasks and instead involves rethinking how work is organized across the health system. He pointed to Suki’s dual approach — delivering AI directly to clinicians through its own application, Suki for Clinicians, while also powering AI capabilities within platforms healthcare organizations already use — as a reason to back the company’s strategy.
The funding announcement followed the rollout of a new Suki tool that integrates Wolters Kluwer’s UpToDate Expert AI API into the Suki for Clinicians app. Dubbed Ask, the tool lets clinicians pose complex clinical questions inside the Suki app and receive answers that are grounded in UpToDate’s proprietary content. Suki and Wolters Kluwer said this is the first product integration of the UpToDate Expert AI API.
Soni positioned Ask and similar integrations as examples of moving past ambient documentation toward AI that contributes clinical reasoning within workflows. The company emphasized that its aim is not to build every capability internally but to bring together complementary AI offerings that work seamlessly for clinicians and health systems.
Soni argued that many health systems are coping with too many disconnected point solutions that add complexity rather than reduce it. In response, Suki is pursuing what it describes as a connected, intelligent operating system for healthcare. That approach seeks to combine clinical, financial and operational AI capabilities so they operate across workflows rather than remaining confined to single applications.
The company’s stated goal is to assemble the best of healthcare AI through direct applications and partner integrations, delivering technology that supports clinicians and health systems across multiple use cases.
New participants in the Series E include Healthier Capital, Crosslink Capital and Hercules Capital. Existing backers that also joined the round include Venrock, Flare Capital Partners, Hedosophia, Philips Ventures and Zoom Ventures. As part of the financing, Healthier Capital’s Aman Mahajan, M.D., Ph.D., will join Suki’s board.
Soni and other executives underscored the board addition and the investor mix as aligned with Suki’s push to scale commercially and deepen clinical and technology partnerships.
According to the company, the capital will fund continued investment in its AI capabilities, the expansion of its commercial team and the scaling of its partner ecosystem. The company intends to combine in-house products like Suki for Clinicians with partner integrations such as the Ask tool linked to UpToDate content to deliver a broader set of AI-driven capabilities across health systems.
Specific product road map details and timelines beyond the Ask integration were not reported in the announcement. The company positioned its strategy as focused on enabling healthcare organizations to reduce fragmentation among AI tools and to adopt intelligence that spans clinical, financial and operational workflows.
Suki’s messaging places it among vendors that aim to embed AI into clinician workflows and enterprise systems rather than delivering isolated point solutions. The company’s combination of direct clinician-facing applications and partner integrations reflects a common approach in the sector: scale through both proprietary products and platform partnerships.
Suki’s reported usage growth, revenue trajectory and partner count were shared by company executives as indicators of market traction. Beyond the Ask integration and the Series E financing, the announcement stressed the company’s longer-term ambition to serve as foundational infrastructure for how healthcare operates in a future shaped by connected AI capabilities.
(Reporting based solely on the company’s funding announcement and executive statements; no independent verification of metrics was reported in the source.)
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.